Floatz logo

(+)-VINCRISTINE

Digestive System Carcinoma

M.D. Anderson Cancer CenterSmall moleculePhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

10 Active assets in the Digestive System Carcinoma cohort.

Asset / SponsorPhaseRating
apd356
Ohio State University Comprehensive Cancer Center
Phase 1CC
Cediranib
M.D. Anderson Cancer Center
Phase 1CC
Valproic Acid
M.D. Anderson Cancer Center
Phase 1CC
Temsirolimus
M.D. Anderson Cancer Center
Phase 1CC
[68ga]ga-nota-t4
RenJi Hospital
N/AD

View all 14 →

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →